Sensitivity-based optimization for the design of a grating interferometer for clinical X-ray phase contrast mammography by Arboleda, Carolina et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Sensitivity-based optimization for the design of a grating interferometer for
clinical X-ray phase contrast mammography
Arboleda, Carolina; Wang, Zhentian; Koehler, Thomas; Martens, Gerhard; Van Stevendaal, Udo;
Bartels, Matthias; Villanueva-Perez, Pablo; Roessl, Ewald; Stampanoni, Marco
Abstract: An X-ray grating interferometer (GI) suitable for clinical mammography must comply with
quite strict dose, scanning time and geometry limitations, while being able to detect tumors, microcal-
cifications and other abnormalities. Such a design task is not straightforward, since obtaining optimal
phase-contrast and dark-field signals with clinically compatible doses and geometrical constraints is re-
markably challenging. In this work, we present a wave propagation based optimization that uses the
phase and dark-field sensitivities as figures of merit. This method was used to calculate the optimal
interferometer designs for a commercial mammography setup. Its accuracy was validated by measuring
the visibility of polycarbonate samples of different thicknesses on a Talbot-Lau interferometer installed on
this device and considering some of the most common grating imperfections to be able to reproduce the
experimental values. The optimization method outcomes indicate that small grating pitches are required
to boost sensitivity in such a constrained setup and that there is a different optimal scenario for each
signal type.
DOI: https://doi.org/10.1364/oe.25.006349
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-150510
Published Version
Originally published at:
Arboleda, Carolina; Wang, Zhentian; Koehler, Thomas; Martens, Gerhard; Van Stevendaal, Udo; Bar-
tels, Matthias; Villanueva-Perez, Pablo; Roessl, Ewald; Stampanoni, Marco (2017). Sensitivity-based
optimization for the design of a grating interferometer for clinical X-ray phase contrast mammography.
Optics Express, 25(6):6349.
DOI: https://doi.org/10.1364/oe.25.006349
Sensitivity-based optimization for the design of
a grating interferometer for clinical X-ray phase
contrast mammography
CAROLINA ARBOLEDA,1,2,* ZHENTIAN WANG,1,2 THOMAS 
KOEHLER,3 GERHARD MARTENS,3 UDO VAN STEVENDAAL,3 
MATTHIAS BARTELS,3 PABLO VILLANUEVA-PEREZ,1,2 EWALD 
ROESSL,3 AND MARCO STAMPANONI 1,2
1Paul Scherrer Institute, 5232 Villigen, Switzerland
2ETH Zurich, 8092 Zurich, Switzerland
3Philips Research Laboratories, D-22335 Hamburg, Germany
*carolina.arboleda@psi.ch
Abstract: An X-ray grating interferometer (GI) suitable for clinical mammography must comply
with quite strict dose, scanning time and geometry limitations, while being able to detect tumors,
microcalcifications and other abnormalities. Such a design task is not straightforward, since
obtaining optimal phase-contrast and dark-field signals with clinically compatible doses and
geometrical constraints is remarkably challenging. In this work, we present a wave propagation
based optimization that uses the phase and dark-field sensitivities as figures of merit. This method
was used to calculate the optimal interferometer designs for a commercial mammography setup.
Its accuracy was validated by measuring the visibility of polycarbonate samples of different
thicknesses on a Talbot-Lau interferometer installed on this device and considering some of
the most common grating imperfections to be able to reproduce the experimental values. The
optimization method outcomes indicate that small grating pitches are required to boost sensitivity
in such a constrained setup and that there is a different optimal scenario for each signal type.
c© 2017 Optical Society of America
OCIS codes: (170.3830) Mammography; (110.7440) X-ray imaging; (080.2740) Geometric optical design; (070.7345) 
Wave propagation; (050.1950) Diffraction gratings.
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1. Introduction
The contribution that X-ray grating based phase-contrast imaging can make to mammography
has been investigated by several research groups in the last few years [1]. Stampanoni et
al [2] measured native mastectomy samples on a Talbot-Lau grating interferometer (GI) and
demonstrated that the differential phase-contrast and dark-field signals provided complementary
information to the conventional attenuation signal. Later on, Hauser [3] conducted a two-section,
prospective independent reader study with six international, expert breast radiologists, who
evaluated both conventional and phase-contrast mammograms of fresh mastectomy samples of
33 patients with invasive cancer. The results of the comparison between the outcomes of both
methods revealed that phase-contrast mammography was able to provide images with superior
quality, increased sharpness, lesion delineation and microcalcification visibility, and clearer
delimitation of the anatomic components of the specimens. In conclusion, the overall clinically
relevant information yielded by this new technique was judged to be superior.
Likewise, Anton et al [4] investigated six mastectomy samples on a Talbot-Lau interferometer.
They demonstrated that it was possible to see important structures on the dark-field images with
significantly higher contrast than on the traditional mammogram. In addition, they compared the
dark-field signal with histomorphometric images and proved that it correlated with a tumor area
containing microcalcifications in the 3-30 µm range. In the meantime, Scherer et al [5] applied a
bi-directional phase-contrast mammography approach to a freshly dissected cancerous breast
sample and were able to reliably detect tumor structures independently from their orientation
within the breast. Later on, Scherer et al [6] presented the first dose-compatible and fast scan-
time phase-contrast images of both a freshly dissected cancerous mastectomy sample and a
mammographic accreditation phantom.
These outcomes have encouraged the medical and scientific community to pursue the transfer
of the phase-contrast technology to the clinics [7,8], which represents a very interesting challenge
from the engineering point of view. This step implies the adaptation of the technique to cover a
large field of view within a limited exposure time, deliver a radiation dose below 1 mGy per view,
be compact in order to comply with the current ergonomic requirements, avoid increasing patient
discomfort and yield higher sensitivity to tumors, microcalcifications and other abnormalities [9].
Based on these facts, a straightforward approach would be to design a GI that can fit into an
already existing commercial mammography machine.
Following this direction, Koehler et al [10] designed and built a first Talbot order GI with a total
length of 55 cm, which they managed to accommodate into a Philips Microdose Mammography
setup that features single photon count Silicon microstrip detectors in a scanning geometry able
to provide a reduction of the dose. The signal retrieval method was integrated into the scanning
motion, so the phase stepping procedure usually employed in conventional GI [11] was avoided.
In the scanning approach, a fringe pattern is generated and phase stepping is achieved by moving
the object on a path perpendicular to the grating direction [12]. Despite this attempt proved
to be able to retrieve absorption, differential phase-contrast and dark-field signals, it yielded a
considerably low sensitivity for a mammographic application.
In order to overcome this issue, a wave propagation based optimization focused on maximiz-
ing the phase and dark-field sensitivities was developed and used to calculate the optimal GI
parameters for the aforementioned Philips device. The predicted values were confronted with
actual measurements to verify the accuracy of the algorithm. To be able to reliably reproduce the
experimental values, the influence of some of the most common grating fabrication imperfections
was assessed as well. Since this setup is designed for a very specific type of sample (i.e. human
breasts), a screening database from Soedersjukhuset, Sweden (use of the screening data for
general research purposes was done in accordance with local legislation), was used to define the
highest occurrence breast, dubbed the target breast in the following, which was utilized for the
calculation of our sensitivity metrics.
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2. Methods
2.1. Philips Microdose Mammography setup
The boundary conditions for the design of a GI for the Philips Microdose Mammography are
listed in Table 1. Since the X-ray tube focal spot size is 300 µm, a source grating (G0) is necessary
to obtain the required spatial coherence [13]. The configuration of this interferometer is sketched
in Fig. 1.
Table 1. Philips Microdose Mammography boundary conditions for the GI design.
Parameter Value
Maximum GI length (cm) 55.6
Peak voltages (kVp) 26, 29, 32, 35 and 38
mAs range 150-1500
Focal spot size (µm) 300
Target material W
Detector technology Si-strip photon-counting
Si-strip thickness (mm) 3.6
Pixel pitch (µm) 50
Image matrix (pixels) 4800 × 5200
Field size (cm × cm) 24 × 26
Detector
Up to 4 cm
Breast
G1
G2
Post-collimator
Focal spot
G0
Pre-collimator
Fig. 1. Sketch of a Talbot-Lau interferometer installed on the Philips Microdose Mammog-
raphy.
2.2. Figures of merit
2.2.1. Phase sensitivity
The Signal-to-Noise Ratio (SNR) for the phase signal can be expressed as:
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SNRφ =
φ
∆φ
= α
2pid
p2
1
∆φ
, (1)
where α is the refraction angle, d is the G1-G2 distance and p2 is the G2 pitch. φ corresponds to 
the differential phase signal and can be defined as follows:
φ = φbackground − φsample , (2)
Using error propagation and assuming that the sample and background uncertainties are
uncorrelated:
∆φ =
√
∆φbackground
2 + ∆φsample
2 , (3)
Since α is object dependent, our objective will be to minimize the inverse of the remaining
factor to optimize the geometry for SNR, i.e:
αmin =
p2
2pid
∆φ, (4)
which is also known as the minimum detectable refraction angle [14]. Revol et al [15] derived the 
dependency of ∆φ for a photon-counting detector as follows:
∆2φ =
2
V r2N
(
1 +
1
TV 2
)
, (5)
V
where V r is the background visibility (i.e. calculated from the scan without object), V is the 
visibility reduction, i.e. V r
s 
, V s being the object visibility, T is the sample transmission and N
is the number of detected photons. The visibility is the contrast of the recorded phase-stepping
curve or Moiré fringe [16].
Although the minimum detectable refraction angle can give us an idea of the sensitivity of
a GI, what the phase-contrast technology ultimately aims to measure is the electron density
(ρe) of a material. Therefore, a more adequate way of expressing the phase sensitivity is as the
minimum detectable electron density gradient. Having the minimum detectable refraction angle,
calculating the latter can be done as follows [17]:
∆ρe ,min =
2pi
reλeff2
αmin , (6)
where re is the classical electron radius and λeff is a weighted average of the wavelengths of the 
detected spectrum after the sample, using the spectral visibility as the weighting factor [16].
2.2.2. Dark-field sensitivity
The dark-field signal might represent an important contribution to mammography, since it could
help detect microcalcifications that are not visible on absorption [4, 18], distinguish between
microcalcification types [19], estimate breast density [20] and potentially differentiate tumors
from harmless masses. This signal reflects the small and ultra-small angle scattering (SAXS
and USAXS) produced by an object. The USAXS and SAXS signals are generated by the
unresolved microscopic structure of the refractive index and cause angular divergence of the
incident beam [21]. In grating-based methods, this effect causes a visibility reduction (V ) at the
detector plane.
The dark-field sensitivity is defined as the corresponding SNR in this paper, i.e:
SNRdf =
−ln(V )
∆ln(V )
, (7)
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whose computation requires the calculation of the visibility reduction produced by the sample. 
The corresponding dark-field signal can be expressed as follows [21–23]:
ln(V ) = −µdt = Σt(G(ξ) − 1), (8)
where Σ is the macroscopic scattering cross-section, t is the sample thickness, G(ξ) is the real-
space correlation function, µd is the dark-field extinction coefficient and ξ is the auto-correlation 
length, i.e:
ξ =
λeffLs
p2
, (9)
where Ls is equivalent to the inter-grating distance if the sample is placed on the G1 plane [23]. 
This means that to be able to predict the visibility reduction produced by breast tissue, we need 
to derive its corresponding G(ξ).
To achieve this goal, we utilized the data from Fernandez et al [24], who measured the USAXS
and SAXS patterns (I (q)) from cancer-bearing human breast tissue. To derive G(ξ) from their
measurements, we started by regenerating their USAXS curve approximating the first portion as
Gaussian and the second one as linear. Afterwards, we fitted this curve to our measurements and
eventually took the inverse Fourier transform to get G(ξ) [23].
We measured two formalin-fixed breast specimens with thicknesses of 2.5 cm and 3.6 cm
at different ξ and used the data from our fresh mastectomy dataset [3] containing 50 samples.
Measurements were conducted on a GI operated with an X-ray tube at 40 kVp. This interferometer
has a design energy of 28 keV, a G0 pitch p0=12.13 µm, G1 pitch p1=4.80 µm, G2 pitch
p2=3.00 µm and a total length of 110 cm. The auto-correlation length was varied by moving
the sample away from G1 and towards G0, and measurements were carried out in the range
of auto-correlation lenghts reachable on the Microdose setup. Since data were acquired on a
polychromatic setup, the corresponding λeff was calculated by measuring a PMMA wedge with
a 45 degree slope and computing the effective energy from the measured refraction angle.
To calculate the visibility reduction produced by a specimen of a certain thickness, we
convoluted the background interference pattern for each λ with the scattering angle distribution
f (x), which can be well approximated as a Gaussian:
f (x) =
1
σ
√
2pi
exp
[
− 1
2σ2
( x
d
)2]
, (10)
where σ is defined as:
σ =
√
Σt(G(ξ) − 1)
2pi2
(
d
p2
)2 , (11)
so that Eq. (8) is satisfied [25].
Afterwards, we performed the usual weighted average using the normalized spectrum to define
the corresponding weights to calculate the effective sample interference pattern [16].
To complete the calculation of Eq. (7), ∆ln(V ) can be computed using noise propagation as
follows:
∆ln(V ) =
√(
∆V s2
V s2
)
+
(
∆V r2
V r2
)
, (12)
where ∆Vs and ∆Vr correspond to the uncertainties in the sample and background visibilities, 
respectively, and it was assumed that both uncertainties are uncorrelated. Revol et al [15] found 
that this noise variance is equivalent to:
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∆2ln(V ) =
2
V r2N
(
1 +
1
TV 2
)
+
1
N
(
1 +
1
T
)
, (13)
It is important to remark that this formula, as well as Eq. (5), only considers the noise
contributed by the detector, which is the major source of uncertainty. There can be other possible
sources of error, such as those due to mechanical motion (phase stepping or scanning), but
these will not be considered in this work, as their contribution is much smaller compared to the
detector [15].
It must be mentioned that our derivation of µd does not take into account all the potential
scatterer shapes and packing distributions that can be encountered in a sample as complex as a
human breast. This complexity stems from the fact that there is a very large biological variability,
which is extremely challenging to take into account in a complete manner. However, we think that
our approach is sufficient for the purpose of this paper, which is to select the optimal GI design
scenario for a constrained setup after comparing all the possibilities under the same conditions.
Notwithstanding, we are aware of the importance of the absolute visibility and sensitivity values,
so we plan to conduct a systematic statistical study on the structures of interest as future work.
2.3. Optimization procedure
A wave propagation code [16, 26] written in Matlab (Mathworks, 2015a) was used to simulate
all the potential GI designs for the Philips Microdose setup taking into account the geometric
constraints. The total GI length was fixed to 55.6 cm, whereas the inter-grating distance was
limited to 4 cm, which is the space available between the breast support and the detector.
The input spectra corresponding to the available peak voltages (see Table 1) were simulated
using the algorithm introduced by Boone et al [27]. For designing GI based systems the input
spectra accuracy is even more crucial than for X-ray attenuation based setups, since the spectrum
shape determines the optimal design energy and the flux absolute values have a major influence
in the sensitivity to phase and dark-field changes induced by the sample. The spectra are plotted
in Fig. 2 and they already take into account the attenuation produced by the compression paddles
(Polycarbonate, 3.66 mm), breast support (Carbon-Fiber-Reinforced Plastic (CFRP), 0.94 mm),
gratings and grating wafers. All gratings were assigned a duty cycle of 0.5. The number of
photons per pixel for an exposure time of 15 s reported in this figure corresponds to the expected
mean photons over the phase stepping curve in the central detector pixel; this value was directly
measured on a GI-equipped Philips setup [10]. Since the duty cycle of the simulated G0 was 0.5,
whereas that of the experimental setup was 0.4, the flux values were corrected by this ratio. The
grating wafers were simulated as Silicon structures with a height of 250 µm. The G1 height is
defined by the design energy, while that of the absorption gratings is calculated as to block the
highest percentage of photons as possible to optimize interference visibility. Considering current
fabrication constraints, which at present limit the aspect ratio of absorption gratings [16], we
used a height of 30 µm for the absorption gratings.
Wave propagation was carried out for each 0.5 keV energy bin independently and their
contributions were incoherently summed up regarding their relative weight within the normalized
spectrum to obtain the resulting phase stepping curve; Poisson noise was added to the latter
afterwards. Moreover, the height of the Silicon strip detectors (3.6 mm) [28] was considered as
well. A summary of the wave propagation algorithm is presented in a flux diagram in Fig. 3.
A pi phase grating was selected for our optimization procedure, since for Talbot orders higher
than 1, the use of a pi/2 grating causes a significant visibility drop due to the sign inversion of
the fringes for some energies of the input spectrum. This negative effect becomes more relevant
as the Talbot order increases, while for Talbot order one it conversely causes a slight visibility
improvement, because the sign inversion does not occur in this case [29]. However, the latter
improvement is so small that can be disregarded.
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Fig. 2. Simulated spectra after all the GI elements (gratings plus grating wafers) on the beam
path assuming 250 µm thick grating wafers for an exposure time of 15 s.
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Fig. 3. Summary of the wave propagation simulation.
For the sensitivity metrics computation, a target breast was selected from a screening popu-
lation comprising 6788 patients that were examined with a Philips Microdose SI system with
spectral capabilities, at Soedersjukhuset, Stockholm, Sweden. The highest-occurrence (25.9
%) breast corresponds to an average compression thickness of 7 cm and a glandular density of
18.1 %. The breast density values were calculated with the built-in breast-density measurement
tool in the Philips system, for which the spectral image data was decomposed into volumes of
glandular and adipose tissue by calibration on tissue-equivalent material [30–32]. The attenuation
coefficient of this target breast was calculated using the XCOM photon cross section database of
the National Institute of Standards and Technology (NIST) [33], utilizing the breast adipose and
glandular tissue compositions defined by the International Commission on Radiation Units and
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Measurements (ICRU) in report 46.
For the calculation of the differential phase and dark-field noise standard deviations, Poisson
noise was added to the object and flat phase-stepping curves. Afterwards, Fourier Component
Analysis was applied to retrieve the aforementioned signals. The noise addition procedure was
repeated until each signal converged to a constant value so that the standard deviation across
iterations could be taken as the uncertainty [14]. The resulting standard deviations were further
validated by the analytical formulas derived by Revol et al [15].
Due to the low photon fluxes we are working with, the highest flux spectrum was used for our
simulations and the design energy range was set to 20-36 keV (Fig. 2). For each design energy,
the corresponding p2 value was calculated, taking into account all the remaining constraints. A
summary of the optimization algorithm is presented in Fig. 4.
(For i=1…Number of design energies) 
G2 pitch calculation 
Δρe,min and SNRdf 
computation 
Wave 
propagation 
Without sample With target breast 
Choose i where Δρe,min is minimum Choose i where SNRdf  is maximum 
Optimal phase scenario Optimal dark-field scenario 
Fig. 4. Summary of the optimization algorithm. An optimal scenario for the phase sensitivity
and another for the dark-field SNR are the outcomes of this method.
2.4. Experimental validation
The accuracy of simulations was validated by measuring the visibility reduction produced by
Polycarbonate blocks of different thicknesses (0, 20 and 40 mm) on a first order Talbot-Lau
interferometer installed in the Philips Microdose using all the available spectra. To be able to
reproduce the experimental values, two of the most common grating imperfections, namely in
the grating heights and duty cycles (i.e. opening/pitch), were simulated. Only the worst-case
scenario values were computed, i.e. having the maximum errors in both parameters and all three
gratings at the same time, which according to the fabrication experts are 10% for the height
and 20% for the duty cycle. In addition, it was assumed that the scattering produced by the
Polycarbonate blocks was negligible.
The GI used for measurements has a total length of 55 cm, a design energy of 25 keV, p0=27.3
µm, p1=3.73 µm, p2=2 µm and an inter-grating distance of 3.75 cm [10]. A source grating with
a duty cycle of 0.4 and a thickness of 30 µm was used for these measurements. By verifying
the visibility accuracy and using realistic flux values, the uncertainty values (∆ln(V ) and ∆φ)
get validated as well, since there is an inter-dependency between these metrics, as discussed in
section 2.2.
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3. Results and discussion
3.1. Experimental validation
The complete set of results of the experimental visibility validation are presented in Fig. 5.
The standard deviation in the predicted values accounts for the variability introduced by the
simulated grating height (±10%) and duty cycle (±20%) imperfections. The thickest block (40
mm) visibility could not be measured with the 26 kVp spectrum, because the SNR was not
enough to provide a reliable value.
It can be seen that it is hard to predict with full accuracy the visibility due to several experi-
mental factors listed below. In an ideal scenario, this trend depends mainly on two factors: 1)
The match between the effective energy of the hardened spectrum and the design energy of
the interferometer; the closer this match, the higher the visibility; 2) the scattering produced
by the sample, that is highly material-dependent and was assumed to be negligible in this case.
However, in practice, other factors also influence this behavior, such as material impurities,
grating imperfections and misalignments, as well as mechanical instabilities. For instance, an
error in the phase grating height will cause the desired phase shift (either pi or pi/2) at an energy
different from the design energy so that the predicted variation of the visibility with respect to
the input spectrum will differ from the experimental behavior. Therefore, what a simulation tool
is able to provide is a range in which the measured visibility values can be expected.
It can be seen on this figure that the experimental values are consistently located at the lowest
parts of the simulated bars for the 32 kVp through 38 kVp spectra; however, this is not the case
for the lower energy spectra. This can be related to the complex distribution of X-ray emission in
the 7 keV-12 keV range for Tungsten, which results in difficulties to simulate low-energy spectra
with high accuracy [27]. The fact that the measured values are systematically found at the lowest
part of the simulated bars for the higher energy spectra might be due to an underestimation of
the real grating fabrication errors.
As explained above, we did not expect to obtain the same measured visibility absolute values
with our simulation tool. However, the fact of being able to reproduce the visibility behavior
with respect to thickness and spectrum within the most common potential grating fabrication
errors is enough to validate the accuracy of our software. In addition, one grating can differ a lot
from another in practice, due to the difficulties to have full control over the fabrication process,
so there could be local height inhomogeneities (i.e. some grating lines being higher than others)
or line distortions (e.g. lines not being straight) which would be hard to account for.
3.2. Derivation of the real-space correlation function for breast tissue
A plot of the derived breast tissue dark-field extinction coefficient µd (Eq. (8)) is presented in
Fig. 6 including the outcomes of the measurements performed on our setup. The value reported
on this figure for the fresh mastectomy database corresponds to the mean of the values presented
in Fig. 7.
A good agreement between the data from [24] and ours is observed. The standard deviation in
our measurements accounts mainly for the inhomogeneity of the tissue rather than the noise.
It is important to mention that the breast glandular density was not taken into account. For
future work, it would be ideal to include this variable into play and of course to increase statistics,
because human breast tissue is subject to a significant biological variability. However, we consider
that for the purpose of this optimization, this derivation is fair enough.
A fundamental issue for the dark-field signal is the optimization task. Here we are optimizing
for breast tissue SNR, but if the diagnostic task is changed, the optimal parameters might
change as well. For instance, if the goal of this instrument was to make visible on the dark-field
image microcalcifications that cannot be seen in absorption, the goal would become to optimize
for microcalcification dark-field contrast-to-noise ratio (CNR). For this purpose, it would be
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Fig. 5. Experimental (pink) and simulated (black bars) visibility values (%) for different
Polycarbonate (PC) thicknesses and spectra. The standard deviation in the simulated values
accounts for the potential grating height and duty cycle imperfections, while it refers to the
noise in the experimental results.
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Fig. 6. Dark-field extinction coefficient (µd ) for breast tissue as a function of the auto-
correlation length. It can be seen that the detected visibility reduction changes with the
auto-correlation length in a sigmoid manner for auto-correlation lengths below 20 µm, which
suggests that the scatterers in the breast have roughly this size.
necessary to derive G(ξ) for different types of microcalcifications (i.e. different shapes and
clustering levels).
3.3. Selection of the optimal GI parameters for the Philips Microdose Mammography
setup
The outcomes of our simulations are presented in Fig. 8. The optimal designs for each Talbot
order with their corresponding sensitivity values are summarized in Table 2. As to the phase,
it can be seen that the optimal values for all the Talbot orders are very close to one another,
although it would be necessary to validate experimentally with breast samples what an increase
of 0.2 electrons/(Å3) means in terms of image quality. The third Talbot order appears to be the
optimal for this metric, at a design energy of 23 keV and demanding a p2 of 1.24 µm. This value
is quite challenging from the fabrication point of view, so maybe the only realistic option would
be to work at a first Talbot order, which does not require such a small pitch. Regarding dark-field,
it can be seen that the best scenario is a 7th Talbot order. However, it demands a p2 of 0.82 µm,
which is even more challenging than the optimal for the phase.
The optimal design scenario is different for both metrics and this can be explained as follows.
The measured phase shift, which has a direct dependency on the electron density gradient(Eqs.
(4) and (6)), will increase as p2
d
becomes smaller; since d is fixed in our case, the only way
to decrease this ratio is by increasing the design energy so that the calculated p2 decreases.
However, the minimum detectable electron density also depends on the phase noise standard
deviation that is determined by the background visibility, the visibility reduction, the flux and
the sample transmission (Eq. (5)). The sample transmission and the flux are independent on the
GI design scenario, so the differences in sensitivity behavior among various scenarios are due to
the background visibility and visibility reduction trends. For the same inter-grating distance, as
the Talbot order increases and p2 decreases, the auto-correlation length increases and thus the
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Fig. 7. Dark-field extinction coefficients (µd ) for our fresh mastectomy database.
Table 2. Optimal scenarios for each Talbot order. For orders 1, 3 and 7, the optimal scenarios
for both signals are the same, whereas for order 5 there are different optimal scenarios for
phase1 and dark field2.
Talbot Design p2 Electron Dark-field
order energy (keV) (µm) density (Å−3) (1/SNR)
1 23 2.16 1.37 1.81
3 23 1.24 1.13 1.02
51 25 0.92 1.22 0.83
52 24 0.94 1.23 0.82
7 23 0.82 1.23 0.69
visibility reduction gets higher (Fig. 6), i.e. the phase noise standard deviation is larger. Taking
all these factors into account, the optimal phase sensitivity scenario corresponds to one at which
the best compromise between the geometric factor and the noise behavior is found.
In the dark-field signal case, the sensitivity metric is expressed as an SNR. The noise behavior
of this signal follows the same dependency as the phase (Eqs. (5) and (13)). However, the signal
itself also improves as the visibility reduction gets higher. Hence, the optimal dark-field scenario
evidences this compromise between the signal and noise standard deviation trends by showing a
low design energy and a high Talbot order, i.e. to make the auto-correlation length large, but not
as large as to cause the noise to increase more than the signal.
To evidence why a higher Talbot order may be more useful in terms of dark-field sensitivity,
the background and target breast visibility values for the optimal dark-field design energy are
reported in Table 3. It is interesting to notice that the visibility difference between breast and
background is minimal for the first Talbot order. As the latter increases, this difference and thus
detectability in terms of dark-field, becomes larger.
The visibility decay produced as the Talbot order is increased is caused by the corresponding
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Fig. 8. Dark-field (top) and electron density (bottom) sensitivity vs. design energy for an
inter-grating distance of 4 cm.
reduction in the spectral acceptance of the interferometer. This trend is confirmed by the formula
derived in [29] for polychromatic visibility, as can be seen on the second column of Table 3.
The difference in absolute values between the latter and our calculations is due to the fact that
this formula assumes perfect spatial coherence and gratings, whereas our simulations take into
account the finite focal spot size [34], limited grating heights, grating wafer thicknesses and
detector stopping power.
The highest flux spectrum (i.e. 38 kVp) was used for our calculations because of the flux
reduction caused by the introduced optical elements. It is also expected that this spectrum will
yield the best sensitivity values. To verify this assumption, we computed the phase and dark-
field sensitivities at the optimal design energy for each spectrum regarding the aforementioned
constraints and the outcomes are presented in Table 4; it can be seen that there is a sensitivity
gain by using the 38 kVp spectrum. However, although the SNR of the attenuation image is
expected to be better by utilizing this spectrum, its soft tissue contrast might decrease for low
breast thicknesses.
We measured the air kerma (K) on a Philips Microdose setup equipped with a G0 grating with
a duty cycle of 0.5, a wafer thickness of 300 µm and a gold height of 30 µm. The measuring
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Table 3. Visibility values (%) predicted by Thüring’s formula and obtained from wave-optics
simulations for the optimal dark-field sensitivity design energy (23 keV).
Talbot Background Background Breast
order (Thuering’s) (simulated) (simulated)
1 49.9 36.1 33.3
3 35.2 27.1 21.8
5 32.6 23.2 16.2
7 34.5 23.5 14.8
Table 4. Phase and dark-field sensitivities for the optimal design scenario at each available
Microdose spectrum.
Spectrum Minimum detectable Dark-field
(kVp) electron density (Å−3) sensitivity (1/SNR)
26 2.90 1.74
29 2.02 1.19
32 1.36 0.93
35 1.25 0.79
38 1.13 0.69
device was an ion chamber and it was placed on the breast support. At 38 kVp, we obtained
a value of K=14.5 mGy and a half-value layer of 0.213 mm Al for an exposure time of 15 s.
According to the European guidelines [35], the mean glandular dose (D) can be calculated as
follows:
D = Kcgs, (14)
where g is a factor corresponding to a glandularity of 50 %, c corrects for any difference in 
breast composition from 50 % glandularity, and s corrects for differences due to the choice of 
X-ray spectrum. The values g and c were calculated for our target breast by interpolation of the 
values reported in tables A5.1 and A5.2 [35], respectively. A resulting dose of 1.47 mGy was 
obtained. Since the maximum achievable value for this thickness (7 cm) is 3.1 mGy [35], the 
input flux could be more than doubled. An increase in flux would significantly contribute to 
improve the quality of the dark-field and differential phase contrast images.
One might think that an alternative scheme, allowing the use of longer inter-grating distances
to obtain a higher sensitivity or larger p2 values without making the GI less sensitive, is to
position the breast between G1 and G2. We could make profit of the fact that the pre-collimator-
detector separation is fixed and independent on the compression thickness for the selection of
the inter-grating distance and place G1 onto the pre-collimator. However, this would imply that
thinner breasts were placed further away from G1, which would cause an important sensitivity
loss [36]. In addition, the reproducibility of the pre-collimator positions in all directions is very
far from what is needed for an X-ray interferometer, so placing G1 right onto it would not be
optimal. Therefore, using a sample-before-grating geometry is more convenient on this setup.
4. Conclusion
A GI-design optimization procedure employing the phase and dark-field sensitivities as figures of
merit was developed, validated and used to calculate the optimal parameters for an interferometer
that can be fitted into a Philips Microdose Mammography setup. The phase sensitivity was
defined as the minimum detectable electron density gradient, whereas the dark-field sensitivity
was defined as the target breast SNR. It was found that the optimal scenarios are the result of a
compromise between the geometric factor, namely d
p2
, and the noise behavior of both signals,
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which depends on the visibility reduction model, the sample transmission and the background
visibility. For a fixed inter-grating distance of 4 cm, it was found that the optimal scenario for
the phase is a third Talbot order GI with p2 1.24 µm, whereas for dark field is a seventh Talbot
order [37] with p2 0.82 µm. Due to the extensive research on the contributions of the dark-field
signal to mammography, it would be more logical to give preference to this signal and choose the
latter scenario for implementation. An important contribution of this paper is a visibility reduction
model for breast tissue, derived from measurements at different auto-correlation lengths.
Since the available inter-grating distance in this setup is so short, very small p2 values
are required for an improved sensitivity, mostly in the dark-field case. This fact significantly
challenges the grating fabrication capabilities.
Future work will include measuring the dark-field extinction coefficients of different tissue
types (microcalcifications, adipose and glandular), to be able to provide all the missing data for
a clinically relevant system optimization, for example, in terms of dark field contrast-to-noise
ratio.
In conclusion, we are now in the position to predict the performance of GI with respect to
these metrics, so we can utilize our toolbox for future interferometer design tasks.
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